TORONTO, June 17, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“ Silo Wellness” or “the Company”) (CSE: SILO) (FRA: 3K70) (OTC: SILFF), a functional and psilocybin mushroom company offering psychedelic wellness retreats, and Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon“), a biotechnology company focused on developing psychedelic medicines to treat addiction…

Source

Previous articleRevive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics
Next articleAwakn Life Sciences Corp. Announces Completion Of Reverse Takeover Transaction, Release From Escrow Of Private Placement Proceeds, And Final Approval For Listing On Neo Exchange